Restricted disease propagation in multiple system atrophy with prolonged survival

Neuropathology and Applied Neurobiology

Volumn 41, Issue 5, 2015, Pages 681-685

  McCann, Heather ^a   McGeachie, Andrew B ^a,b   Silberstein, Paul ^c   Lewis, Simon J G ^d   Halliday, Glenda M ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Royal North Shore and North Shore Private Hospitals   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; LEVODOPA;

ADULT; BRAIN ATROPHY; CASE REPORT; DISEASE COURSE; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; LETTER; MIDDLE AGED; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME; STRIATONIGRAL DEGENERATION; SURVIVAL TIME; SYMPTOMATOLOGY; TREMOR; BRAIN; COMPLICATION; MULTIPLE SYSTEM ATROPHY; PATHOLOGY; VERY ELDERLY;

AGED, 80 AND OVER; BRAIN; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; LEVODOPA; MULTIPLE SYSTEM ATROPHY;

EID: 84949090552     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12195     Document Type: Letter

References (20)

1. Halliday GM, Holton JL, Revesz T, Dickson DW. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 2011; 122: 187-204
2. Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 2012; 38: 4-24
3. Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 2012; 27: 1186-1190
4. Jellinger K. Long duration of multiple system atrophy. Neuropathology 2012; 32: 586
5. Calandra-Buonaura G, Guaraldi P, Sambati L, Lopane G, Cecere A, Barletta G, Provini F, Contin M, Martinelli P, Cortelli P. Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? Neurol Sci 2013; 34: 1875-1878
6. Kim HJ, Jeon BS. Multiple system atrophy with prolonged survival. Mov Disord 2012; 27: 1834
7. Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012; 8: 1-13
8. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123: 1-11
9. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676
10. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009; 8: 1150-1157
11. Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005; 20 (Suppl. 12): S29-36
12. Wenning GK, Seppi K, Tison F, Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 2002; 109: 307-320
13. Wakabayashi K, Mori F, Nishie M, Oyama Y, Kurihara A, Yoshimoto M, Kuroda N. An autopsy case of early ('minimal change') olivopontocerebellar atrophy (multiple system atrophy-cerebellar). Acta Neuropathol 2005; 110: 185-190
14. Huang Y, Garrick R, Cook R, O'Sullivan D, Morris J, Halliday GM. Pallidal stimulation reduces treatment-induced dyskinesias in 'minimal-change' multiple system atrophy. Mov Disord 2005; 20: 1042-1047
15. Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE. 'Minimal change' multiple system atrophy. Mov Disord 1994; 9: 161-166
16. Abbott SM, Videnovic A. Sleep disorders in atypical Parkinsonism. Mov Disord Clin Pract (Hoboken) 2014; 1: 89-96
17. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005; 4: 605-610
18. Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, Kato K, Fukatsu H, Naganawa S, Kato T, Ito K, Sobue G. Cognitive impairments in multiple system atrophy: MSA-C vs. MSA-P. Neurology 2008; 70: 1390-1396
19. Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, Takeda A, Weintraub D, Wenning GK, Movement Disorders Society MSASG. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Mov Disord 2014; 29: 857-867
20. Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB. Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A 2013; 110: 19555-19560